Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Aerosolized gentamicin reduces the burden of tuberculosis in a murine model.
Roy CJ, Sivasubramani SK, Dutta NK, Mehra S, Golden NA, Killeen S, Talton JD, Hammoud BE, Didier PJ, Kaushal D.
Antimicrob Agents Chemother. 2012 Feb;56(2):883-6. Epub 2011 Dec 5. Erratum in: Antimicrob Agents Chemother. 2012 Mar;56(3):1672.
Related citations
Importance of confirming data on the in vivo efficacy of novel antibacterial drug regimens against various strains of Mycobacterium tuberculosis.
De Groote MA, Gruppo V, Woolhiser LK, Orme IM, Gilliland JC, Lenaerts AJ.
Antimicrob Agents Chemother. 2012 Feb;56(2):731-8. Epub 2011 Dec 5.
Consensus statement on diagnostic end points for infant tuberculosis vaccine trials.
Hatherill M, Verver S, Mahomed H; Taskforce on Clinical Research Issues, Stop TB Partnership Working Group on TB Vaccines.
Clin Infect Dis. 2012 Feb 15;54(4):493-501. Epub 2011 Dec 5.
The use of an automated quantitative polymerase chain reaction (Xpert MTB/RIF) to predict the sputum smear status of tuberculosis patients.
Theron G, Pinto L, Peter J, Mishra HK, Mishra HK, van Zyl-Smit R, Sharma SK, Dheda K.
Clin Infect Dis. 2012 Feb 1;54(3):384-8. Epub 2011 Dec 1.
Live attenuated Salmonella vaccines against Mycobacterium tuberculosis with antigen delivery via the type III secretion system.
Juárez-Rodríguez MD, Arteaga-Cortés LT, Kader R, Curtiss R 3rd, Clark-Curtiss JE.
Infect Immun. 2012 Feb;80(2):798-814. Epub 2011 Dec 5.
Live attenuated Salmonella vaccines displaying regulated delayed lysis and delayed antigen synthesis to confer protection against Mycobacterium tuberculosis.
Juárez-Rodríguez MD, Yang J, Kader R, Alamuri P, Curtiss R 3rd, Clark-Curtiss JE.
Infect Immun. 2012 Feb;80(2):815-31. Epub 2011 Dec 5.
Physicians' attitudes towards self-treatment of latent tuberculosis.
Bhanot N, Haran M, Lodha A, Paul V, Goswami R, Chapnick EK.
Int J Tuberc Lung Dis. 2012 Feb;16(2):169-71.
CCL2−2518 (A/G) polymorphisms and tuberculosis susceptibility: a meta-analysis.
Feng WX, Flores-Villanueva PO, Mokrousov I, Wu XR, Xiao J, Jiao WW, Sun L, Miao Q, Shen C, Shen D, Liu F, Jia ZW, Shen A.
Int J Tuberc Lung Dis. 2012 Feb;16(2):150-6. Review.
Clinical failures associated with rpoB mutations in phenotypically occult multidrug-resistant Mycobacterium tuberculosis.
Williamson DA, Roberts SA, Bower JE, Vaughan R, Newton S, Lowe O, Lewis CA, Freeman JT.
Int J Tuberc Lung Dis. 2012 Feb;16(2):216-20.
Genetic polymorphisms in the P2X7 gene and its association with susceptibility to tuberculosis.
Singla N, Gupta D, Joshi A, Batra N, Singh J.
Int J Tuberc Lung Dis. 2012 Feb;16(2):224-9.
Global isoniazid resistance patterns in rifampin-resistant and rifampin-susceptible tuberculosis.
Smith SE, Kurbatova EV, Cavanaugh JS, Cegielski JP.
Int J Tuberc Lung Dis. 2012 Feb;16(2):203-5.
Recommendations on modern contact investigation methods for enhancing tuberculosis control.
Cook VJ, Shah L, Gardy J, Bourgeois AC.
Int J Tuberc Lung Dis. 2011 Mar;16(3):297-305. Epub 2011 Dec 2.
The cost effectiveness of Nucleic Acid Amplification Techniques for the diagnosis of tuberculosis.
Hughes R, Wonderling D, Li B, Higgins B.
Respir Med. 2012 Feb;106(2):300-7. Epub 2011 Dec 1. Review.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on